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1223. Impact of Donor Lung Gram Stain on Post-Transplant Pneumonia
and Mortality: More Lungs Can Be Used to Save Lives
Sher Ali Khan, MBBS1; Emir Veledar, PhD2; Cathy Logan, MD3; Sanjay Mehta, MD4;
Gordon Yung, MD3; Saima Aslam, MD, MS5; 1Medicine, UC San Diego, San Diego,
California; 2Florida International University, Miami, Florida; 3UC San Diego, San
Diego, California; 4Medicine, University of California, San Diego, La Jolla, California;
5Division of Infectious Disease, University of California, San Diego, La Jolla, California
Session: 158. Transplant Screenings and Evaluation and Empiric and Pre-Emptive
Therapy
Friday, October 9, 2015: 12:30 PM
Background. Donor lungs with Gram-stain (GS) evidence of bacteria on broncho-
scopy specimens are considered infected and generally deemed unsuitable for trans-
plant. We sought to assess the impact of donor lung GS on the occurrence of post-
transplant pneumonia (PTP), length of stay (LOS), and mortality.
Methods. We retrospectively reviewed medical records of all lung transplant recip-
ients (LTR) at our center from December 2004 to February 2014. PTP was deﬁned by
the presence of at least 2 of 3 criteria that occurred within 30 days of transplant: (1)
symptoms, signs or laboratory markers consistent with pneumonia; (2) radiological
evidence; and (3) positive respiratory culture. Statistics: Univariate and multivariate
analyses, Kaplan-Meir (KM) curves, and log-rank test.
Results. Among 149 LTRs, 45 received donor lungs with GS positive for bacteria at
the time of implantation (GS+ group) and 104 received lungs with GS negative for bac-
teria (GS- group). Standard immunosuppression consisted of tacrolimus, mycopheno-
late mofetil and steroids; induction with basiliximab was rarely used. GS+ recipients
spent longer time on the wait-list (mean 416.6 versus 230.6 days, p = 0.007) and
were more likely to have a double lung transplant (80% versus 59.6%, p = 0.02) but
were otherwise similar at baseline. Receipt of GS+ lungs was associated with longer
post-operative ventilator time (mean 277.4 versus 77.1 hours, p = 0.045), along with
prolonged intensive care unit (ICU) and overall LOS (mean 15.9 versus 9.5 days,
p = 0.014; mean 36.2 versus 21.7 days, p = 0.005, respectively). Rate of PTP was similar
in both groups (51% versus 38.5%, p = 0.21) as was overall mortality (31.1% versus
35.6%, p = 0.71) with similar KM curves (ﬁgure, log-rank p = 0.2). In multivariate
analysis, GS+ group remained an independent predictor of ICU stay (OR 5.9, 95%
CI 1.1-10.7, p = 0.016) and LOS (OR 12.6, 95% CI 2.9-22.3, p = 0.01).
Conclusion. Use of donor lungs that are Gram-stain positive for bacteria is asso-
ciated with longer time on the ventilator, and in the ICU and hospital. However, it does
not impact the development of pneumonia in the ﬁrst 30 days post-transplant or mor-
tality. Hence, criteria for use of donor lungs should be liberalized with the potential to
save more lives.
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